Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteinuria in essential hypertension

P S Soni1, D V Doifode, S K Kate

  • 1Indira Gandhi Medical College, Nagpur.

The Journal of the Association of Physicians of India
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.

Journal of aerosol medicine and pulmonary drug delivery·2014
Same author

Inhalational system for Etoposide liposomes: formulation development and in vitro deposition.

Indian journal of pharmaceutical sciences·2012
Same author

Characterization of soy polysaccharide and its in vitro and in vivo evaluation for application in colon drug delivery.

AAPS PharmSciTech·2012
Same author

Development and evaluation of inhalational liposomal system of budesonide for better management of asthma.

Indian journal of pharmaceutical sciences·2011
Same author

Longitudinal changes in corneal asphericity in myopia.

Optometry and vision science : official publication of the American Academy of Optometry·2000
Same author

Optometry's research profile: we are on the way up; how high can we go?

Optometry (St. Louis, Mo.)·2000

Essential hypertension patients showed higher proteinuria than controls. Treatment significantly reduced proteinuria, with enalapril alone yielding the greatest decrease in protein excretion.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Essential hypertension is a significant risk factor for renal damage.
  • Proteinuria is a key indicator of kidney damage in hypertensive individuals.
  • Understanding the impact of antihypertensive treatments on proteinuria is crucial for managing hypertension-related complications.

Purpose of the Study:

  • To quantitatively assess proteinuria in patients with newly detected essential hypertension.
  • To evaluate the effect of different antihypertensive treatments (enalapril, nifedipine, and combination) on proteinuria.
  • To compare the efficacy of enalapril and nifedipine in reducing proteinuria.

Main Methods:

  • Quantitative measurement of proteinuria in 81 newly diagnosed essential hypertension patients and 25 controls.

Related Experiment Videos

  • Hypertension treatment involved enalapril, nifedipine, or a combination, for six weeks.
  • Statistical analysis to compare proteinuria levels before and after treatment, and between treatment groups.

    • Main Results:

    • Patients with essential hypertension exhibited significantly higher mean proteinuria compared to controls (P < .001).
    • Antihypertensive treatment led to a significant reduction in proteinuria after six weeks (P < .001).
    • Enalapril monotherapy demonstrated the most substantial reduction in proteinuria compared to combination therapy or nifedipine monotherapy.

    Conclusions:

    • Elevated proteinuria is a common finding in untreated essential hypertension.
    • Effective control of hypertension significantly mitigates proteinuria.
    • Enalapril appears to be more effective than nifedipine or combination therapy in reducing proteinuria in hypertensive patients without renal insufficiency.